Zimmer Biomet, Spineway, Implanet & more: 12 device company key notes

Anuja Vaidya -   Print  |

Here are 12 key notes on orthopedic and spine device companies from the past week.

Premia Spine launched a pivotal, FDA approval seeking, study of the TOPS system. The first procedure was performed in Pennsylvania.


Spineway reported revenue of about $6.94 million for the first half of 2017, reflecting a 146 percent increase from the same period the year prior.


In the first half of 2017, Implanet saw revenue of about $4.77 million.


Stryker saw an 18.5 percent year over year growth in the first quarter of 2017, according to Market Realist.


A new Inspired Spine study showed 95 percent of patients being treated for symptomatic degenerative spinal deformity using the oblique lateral lumbar interbody fusion procedure were able to walk within 24 hours of surgery.


Emerging Implant Technologies received FDA approval for its full 3-D printed cage portfolio.


Simplify Medical closed a $21 million Series B financing round.


Gregory C. Mallo, MD, and Philip L. Schrank, MD, will leverage Zimmer Biomet's Comprehensive Vault Reconstruction System to perform a shoulder replacement in late July.


EOS named Mike Lobinsky president, North America, a newly created position.


Bioventus expanded its Performance Program for EXOGEN Ultrasound Bone Healing System in Canada.


Spinal Simplicity named Richard Grant a new advisor and member of the company's board of managers.


XinRong Medical welcomed Stephen Ooi to its board of directors.


More articles on devices:
Spinal Simplicity names new board member: 5 takeaways
EOS names Mike Lobinsky president, North America: 5 key notes
Spineway reports $6.9M in revenue for first half of 2017: 4 insights

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers